Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA orphan drugs staff

Executive Summary

Former Center for Biologics Evaluation & Research Office of Cellular, Tissue & Gene Therapies Acting Director Phil Noguchi, MD, joins Office of Orphan Products Development as medical reviewer. Joyce Frey-Vasconcells assumes acting director post at CBER's cell therapies office...

You may also be interested in...



FDA orphan products development

Former Center for Biologics Evaluation & Research Office of Cellular, Tissue & Gene Therapies Acting Director Phil Noguchi, MD, will leave FDA at the end of August. Noguchi has held the position of medical officer within the Office of Orphan Products Development since May (1"The Pink Sheet" May 17, 2004, In Brief)...

EMEA Round-Up: Bayer Strikes Egypt Deals, Orkla Acquires NutraQ, Uriach Grabs Sidroga

Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.

TheOTCLab Scores Dutch Distribution Rights To Just For Men, Vagisil and Breathe Right

Dutch firm TheOTCLab expands its home market presence with distribution rights to three international consumer health brands: Combe's feminine health brand Vagisil and male hair care range Just For Men and Foundation Consumer Brands’ Breathe Right Nasal Strips.

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel